These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24696747)

  • 1. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
    Wang CX; Liu B; Wang YF; Zhang RS; Yu B; Lu ZF; Shi QL; Zhou XJ
    Int J Clin Exp Pathol; 2014; 7(3):1266-74. PubMed ID: 24696747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma.
    Okada F; Takeda M; Fujii T; Uchiyama T; Sasaki S; Matsuoka M; Nitta Y; Terada C; Maebo K; Morita K; Ishida E; Sawabata N; Ohbayashi C
    J Clin Pathol; 2024 Jan; 77(2):111-115. PubMed ID: 36456172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens.
    Zhao L; Huang S; Liu J; Zhao J; Li Q; Wang HQ
    Medicine (Baltimore); 2017 Sep; 96(39):e8153. PubMed ID: 28953659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.
    Krasinskas AM; Chiosea SI; Pal T; Dacic S
    Mod Pathol; 2014 Feb; 27(2):262-70. PubMed ID: 23887294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDX-2 Expression in Primary Lung Adenocarcinoma.
    Cowan ML; Li QK; Illei PB
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):16-9. PubMed ID: 26469326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
    J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status.
    Sousa V; Rodrigues C; Silva M; Alarcão AM; Carvalho L
    Rev Port Pneumol (2006); 2015; 21(3):113-25. PubMed ID: 25926253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas.
    Inamura K; Satoh Y; Okumura S; Nakagawa K; Tsuchiya E; Fukayama M; Ishikawa Y
    Am J Surg Pathol; 2005 May; 29(5):660-5. PubMed ID: 15832091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.
    Matsushima J; Yazawa T; Suzuki M; Takahashi Y; Ota S; Nakajima T; Yoshino I; Yokose T; Inoue T; Kawahara K; Nakatani Y
    Hum Pathol; 2017 Jun; 64():179-185. PubMed ID: 28438615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cribriform adenocarcinoma of the lung: clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma.
    Mackinnon AC; Luevano A; de Araujo LC; Rao N; Le M; Suster S
    Mod Pathol; 2014 Aug; 27(8):1063-72. PubMed ID: 24390215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases.
    Morita S; Yoshida A; Goto A; Ota S; Tsuta K; Yokozawa K; Asamura H; Nakajima J; Takai D; Mori M; Oka T; Tamaru J; Itoyama S; Furuta K; Fukayama M; Tsuda H
    Am J Surg Pathol; 2013 Jun; 37(6):924-32. PubMed ID: 23629442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
    Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
    Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.
    Chen M; Liu P; Yan F; Xu S; Jiang Q; Pan J; He M; Shen P
    J Transl Med; 2018 Mar; 16(1):81. PubMed ID: 29587865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
    de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
    Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary enteric adenocarcinoma indistinguishable morphologically and immunohistologically from metastatic colorectal carcinoma.
    László T; Lacza A; Tóth D; Molnár TF; Kálmán E
    Histopathology; 2014 Aug; 65(2):283-7. PubMed ID: 24571601
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinicopathological and molecular features of pulmonary enteric adenocarcinoma].
    Gao G; Wang YZ; Zhang YP; Feng SE; Hou M; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):544-549. PubMed ID: 32486530
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.
    Maki Y; Soh J; Ichimura K; Shien K; Furukawa M; Muraoka T; Tanaka N; Ueno T; Yamamoto H; Asano H; Tsukuda K; Toyooka S; Miyoshi S
    Oncol Rep; 2013 Jan; 29(1):133-40. PubMed ID: 23076555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.
    Kadota K; Yeh YC; D'Angelo SP; Moreira AL; Kuk D; Sima CS; Riely GJ; Arcila ME; Kris MG; Rusch VW; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2014 Aug; 38(8):1118-27. PubMed ID: 25029118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HNF4α as a marker for invasive mucinous adenocarcinoma of the lung.
    Sugano M; Nagasaka T; Sasaki E; Murakami Y; Hosoda W; Hida T; Mitsudomi T; Yatabe Y
    Am J Surg Pathol; 2013 Feb; 37(2):211-8. PubMed ID: 23108025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.